Intervacc AB (publ) logo

Intervacc AB (publ)

SSE:IVACC.ST

Overview | Financials
Company Name Intervacc AB (publ)
Symbol IVACC.ST
Currency SEK
Price 3.735
Market Cap 282,875,081
Dividend Yield 0%
52-week-range 3.315 - 12.681
Industry Biotechnology
Sector Healthcare
CEO Mr. Jonas Sohlman
Website https://www.intervacc.se

An error occurred while fetching data.

About Intervacc AB (publ)

Intervacc AB (publ), a biotechnology company, engages in the research and development of vaccines for bacterial infections in animal health care. The company devlops vaccines for horses, piglets, and dairy cows. It offers Strangvac, a vaccine for equine strangles. The company also markets and sells veterinary medicines; and provides diagnostic

Related Stocks

IRLAB Therapeutics AB (publ) logo

IRLAB Therapeutics AB (publ)

IRLAB-A.ST

14.45 SEK

Doxa AB (publ) logo

Doxa AB (publ)

DOXA.ST

3.2 SEK

Mentice AB (publ) logo

Mentice AB (publ)

MNTC.ST

34.4 SEK

Vicore Pharma Holding AB (publ) logo

Vicore Pharma Holding AB (publ)

VICO.ST

14.38 SEK

Xbrane Biopharma AB (publ) logo

Xbrane Biopharma AB (publ)

XBRANE.ST

2.085 SEK

RaySearch Laboratories AB (publ) logo

RaySearch Laboratories AB (publ)

RAY-B.ST

92.2 SEK

Elos Medtech AB (publ) logo

Elos Medtech AB (publ)

ELOS-B.ST

203 SEK

Humana AB (publ) logo

Humana AB (publ)

HUM.ST

27 SEK

Q-linea AB (publ) logo

Q-linea AB (publ)

QLINEA.ST

2.49 SEK

Financials

Numbers are in millions USD

Numbers are in millions USD